Pfizer Vaccine Provides Less Immunity to Omicron Variant

Share

Pfizer Inc.’s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain. Bloomberg Intelligence’s Sam Fazeli has the latest on “Bloomberg Markets: Europe.”